AAAAAA
Results: 1-25/37
Authors:
Shapiro, LE
Shear, NH
Citation: Le. Shapiro et Nh. Shear, Drug interactions/P450, CURR P D-US, 13(3), 2001, pp. 141-152
Authors:
Trakas, K
Oh, PI
Singh, S
Risebrough, N
Shear, NH
Citation: K. Trakas et al., The health status of obese individuals in Canada, INT J OBES, 25(5), 2001, pp. 662-668
Authors:
Papp, K
Bissonnette, R
Krueger, JG
Carey, W
Gratton, D
Gulliver, WP
Lui, H
Lynde, CW
Magee, A
Minier, D
Ouellet, JP
Patel, P
Shapiro, J
Shear, NH
Kramer, S
Walicke, P
Bauer, R
Dedrick, RL
Kim, SS
White, M
Garovoy, MR
Citation: K. Papp et al., The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody, J AM ACAD D, 45(5), 2001, pp. 665-674
Authors:
Shapiro, LE
Uetrecht, J
Shear, NH
Citation: Le. Shapiro et al., Minocycline, perinuclear antineutrophilic cytoplasmic antibody, and pigment: The biochemical basis, J AM ACAD D, 45(5), 2001, pp. 787-789
Authors:
Neuman, MG
Brenner, DA
Rehermann, B
Taieb, J
Chollet-Martin, S
Cohard, M
Garaud, JJ
Poynard, T
Katz, GG
Cameron, RG
Shear, NH
Gao, B
Takamatsu, M
Yamauchi, M
Ohata, M
Saito, S
Maeyama, S
Uchikoshi, T
Toda, G
Kumagi, T
Akbar, SMF
Abe, M
Michitaka, K
Horlike, N
Onji, M
Citation: Mg. Neuman et al., Mechanisms of alcoholic liver disease: Cytokines, ALC CLIN EX, 25(5), 2001, pp. 251S-253S
Authors:
Knowles, S
Shapiro, L
Shear, NH
Citation: S. Knowles et al., Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy, DRUG SAFETY, 24(4), 2001, pp. 239-247
Authors:
Ozdemir, V
Shear, NH
Kalow, W
Citation: V. Ozdemir et al., What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?, DRUG SAFETY, 24(2), 2001, pp. 75-85
Authors:
Neuman, MG
Benhamou, JP
Malkiewicz, IM
Akremi, R
Shear, NH
Asselah, T
Ibrahim, A
Boyer, N
Martinot-Peignoux, M
Jacobson-Brown, P
Katz, GG
Le Breton, V
Le Guludec, G
Suneja, A
Marcellin, P
Citation: Mg. Neuman et al., Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C, CLIN BIOCH, 34(3), 2001, pp. 173-182
Authors:
Neuman, MG
Blendis, LM
Shear, NH
Malkiewicz, IM
Ibrahim, A
Katz, GG
Sapir, D
Halpern, Z
Brill, S
Peretz, H
Magazinik, S
Konikoff, FM
Citation: Mg. Neuman et al., Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: role of triple therapy with interferon alpha, ribavirin, and ursodeoxycholate, CLIN BIOCH, 34(3), 2001, pp. 183-188
Authors:
Neuman, MG
Shear, NH
Jacobson-Brown, PM
Katz, GG
Neilson, HK
Malkiewicza, IM
Cameron, RG
Abbott, F
Citation: Mg. Neuman et al., CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity, CLIN BIOCH, 34(3), 2001, pp. 211-218
Authors:
Katz, GG
Shear, NH
Malkiewicz, IM
Valentino, K
Neuman, MG
Citation: Gg. Katz et al., Signaling for ethanol-induced apoptosis and repair in vitro, CLIN BIOCH, 34(3), 2001, pp. 219-227
Authors:
Popat, A
Shear, NH
Malkiewicz, I
Stewart, MJ
Steenkamp, V
Thomson, S
Neuman, MG
Citation: A. Popat et al., The toxicity of Callilepis laureola, a South African traditional herbal medicine, CLIN BIOCH, 34(3), 2001, pp. 229-236
Authors:
Sullivan, JR
Shear, NH
Citation: Jr. Sullivan et Nh. Shear, The drug hypersensitivity syndrome - What is the pathogenesis?, ARCH DERMAT, 137(3), 2001, pp. 357-364
Authors:
Lowitt, MH
Shear, NH
Citation: Mh. Lowitt et Nh. Shear, Pharmacogenomics and dermatological therapeutics, ARCH DERMAT, 137(11), 2001, pp. 1512-1514
Authors:
Knowles, S
Shapiro, L
Shear, NH
Citation: S. Knowles et al., Drug eruptions, CURR P D-US, 12(2), 2000, pp. 58-62
Authors:
Gupta, AK
Maddin, S
Arlette, J
Giroux, JM
Shear, NH
Citation: Ak. Gupta et al., Itraconazole pulse therapy is effective in dermatophyte onychomycosis of the toenail: a double-blind placebo-controlled study, J DERM TR, 11(1), 2000, pp. 33-37
Authors:
Shapiro, LE
Shear, NH
Citation: Le. Shapiro et Nh. Shear, Studying the statins - Reply, CAN MED A J, 162(8), 2000, pp. 1124-1124
Authors:
Gupta, AK
Katz, HI
Shear, NH
Citation: Ak. Gupta et al., Terbinafine and potential drug interactions - Reply, J AM ACAD D, 43(5), 2000, pp. 883-884
Authors:
Gupta, AK
Katz, HI
Shear, NH
Citation: Ak. Gupta et al., Drug interactions with itraconazole, fluconazole, and terbinafine and their management (vol 41, pg 237, 1999), J AM ACAD D, 42(1), 2000, pp. 148-148
Authors:
Knowles, SR
Uetrecht, J
Shear, NH
Citation: Sr. Knowles et al., Idiosyncratic drug reactions: the reactive metabolite syndromes, LANCET, 356(9241), 2000, pp. 1587-1591
Authors:
Gupta, AK
Shear, NH
Citation: Ak. Gupta et Nh. Shear, A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis, DRUG SAFETY, 22(1), 2000, pp. 33-52
Authors:
Neuman, MG
Malkiewicz, IM
Shear, NH
Citation: Mg. Neuman et al., A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes, CLIN BIOCH, 33(7), 2000, pp. 517-524
Authors:
Sullivan, JR
Shear, NH
Citation: Jr. Sullivan et Nh. Shear, What are some of the lessons learnt from in vitro studies of severe unpredictable drug reactions?, BR J DERM, 142(2), 2000, pp. 205-207
Authors:
Shear, NH
Landau, M
Malkiewicz, I
Katz, GG
Neuman, MG
Citation: Nh. Shear et al., Ethanol-modulated cytokine production and expression in skin cells exposedto methotrexate, SKIN PH APP, 12(1-2), 1999, pp. 64-78
Authors:
Gupta, AK
Shear, NH
Citation: Ak. Gupta et Nh. Shear, The new oral antifungal agents for onychomycosis of the toenails, J EUR A D V, 13(1), 1999, pp. 1-13